Search Results - "Yasuhisa Ohata"

Refine Results
  1. 1

    4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts by Takeyari, Shinji, Kubota, Takuo, Ohata, Yasuhisa, Fujiwara, Makoto, Kitaoka, Taichi, Taga, Yuki, Mizuno, Kazunori, Ozono, Keiichi

    Published in The Journal of biological chemistry (01-01-2021)
    “…Osteogenesis imperfecta (OI) is a heritable brittle bone disease mainly caused by mutations in the two type I collagen genes. Collagen synthesis is a complex…”
    Get full text
    Journal Article
  2. 2

    Pathogenic Variants of the PHEX Gene by Ohata, Yasuhisa, Ishihara, Yasuki

    Published in Endocrines (08-08-2022)
    “…Twenty-five years ago, a pathogenic variant of the phosphate-regulating endopeptidase homolog X-linked (PHEX) gene was identified as the cause of X-linked…”
    Get full text
    Journal Article
  3. 3

    Clinical Practice Guidelines for Hypophosphatasia by Michigami, Toshimi, Ohata, Yasuhisa, Fujiwara, Makoto, Mochizuki, Hiroshi, Adachi, Masanori, Kitaoka, Taichi, Kubota, Takuo, Sawai, Hideaki, Namba, Noriyuki, Hasegawa, Kosei, Fujiwara, Ikuma, Ozono, Keiichi

    Published in Clinical Pediatric Endocrinology (01-01-2020)
    “…Hypophosphatasia (HPP) is a rare bone disease caused by inactivating mutations in the ALPL gene, which encodes tissue-nonspecific alkaline phosphatase…”
    Get full text
    Journal Article
  4. 4

    Assessment of body fat mass, anthropometric measurement and cardiometabolic risk in children and adolescents with achondroplasia and hypochondroplasia by Nakano, Yukako, Kubota, Takuo, Ohata, Yasuhisa, Takeyari, Shinji, Kitaoka, Taichi, Miyoshi, Yoko, Ozono, Keiichi

    Published in Endocrine Journal (01-01-2023)
    “…Achondroplasia is a rare skeletal dysplasia characterized by rhizomelic short stature, whose prevalence is about 1 per 25,000 births. For some patients with…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Clinical Practice Guidelines for Achondroplasia by Kubota, Takuo, Adachi, Masanori, Kitaoka, Taichi, Hasegawa, Kosei, Ohata, Yasuhisa, Fujiwara, Makoto, Michigami, Toshimi, Mochizuki, Hiroshi, Ozono, Keiichi

    Published in Clinical Pediatric Endocrinology (01-01-2020)
    “…Achondroplasia (ACH) is a skeletal dysplasia that presents with limb shortening, short stature, and characteristic facial configuration. ACH is caused by…”
    Get full text
    Journal Article
  7. 7

    Alkaline phosphatase in pediatric patients with genu varum caused by vitamin D-deficient rickets by Mukai, Masashi, Yamamoto, Takehisa, Takeyari, Shinji, Ohata, Yasuhisa, Kitaoka, Taichi, Kubota, Takuo, Yamamoto, Katsusuke, Kijima, Eri, Hasegawa, Yasuhiro, Michigami, Toshimi, Ozono, Keiichi

    Published in Endocrine Journal (01-01-2021)
    “…An elevated serum alkaline phosphatase (ALP) level is one of the markers for the presence of rickets in children, but it is also associated with bone…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Potential pathological role of single nucleotide polymorphism (c.787T>C) in alkaline phosphatase (ALPL) for the phenotypes of hypophosphatasia by Matsuda, Nozomi, Takasawa, Kei, Ohata, Yasuhisa, Takishima, Shigeru, Kubota, Takuo, Ishihara, Yasuki, Fujiwara, Makoto, Ogawa, Erika, Morio, Tomohiro, Kashimada, Kenichi, Ozono, Keiichi

    Published in ENDOCRINE JOURNAL (01-01-2020)
    “…Hypophosphatasia (HPP; OMIM 241510, 241500, and 146300) is an inherited metabolic disease characterized by defects of bone and tooth mineralization, which is…”
    Get full text
    Journal Article
  10. 10

    A case of hyperphosphatemic familial tumoral calcinosis due to maternal uniparental disomy of a GALNT3 variant by Nishimura-Kinoshita, Naoko, Ohata, Yasuhisa, Sawai, Hiromi, Izawa, Masako, Takeyari, Shinji, Kubota, Takuo, Omae, Yosuke, Ozono, Keiichi, Tokunaga, Katsushi, Hamajima, Takashi

    Published in Clinical Pediatric Endocrinology (2023)
    “…Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare, inherited autosomal recessive disorder caused by fibroblast growth factor-23 (FGF23),…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients by Islam, Mohammad Saiful, Namba, Noriyuki, Ohata, Yasuhisa, Fujiwara, Makoto, Nakano, Chiho, Takeyari, Shinji, Miyata, Kei, Nakano, Yukako, Yamamoto, Kenichi, Nakayama, Hirofumi, Kitaoka, Taichi, Kubota, Takuo, Ozono, Keiichi

    Published in ENDOCRINE JOURNAL (01-01-2019)
    “…Monocarboxylate transporter 8 (MCT8) facilitates T3 uptake into cells. Mutations in MCT8 lead to Allan-Herndon-Dudley syndrome (AHDS), which is characterized…”
    Get full text
    Journal Article
  13. 13

    Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease by Nagata, Yuki, Miyagawa, Kazuaki, Ohata, Yasuhisa, Petrusca, Daniela N., Pagnotti, Gabriel M., Mohammad, Khalid S., Guise, Theresa A., Windle, Jolene J., David Roodman, G., Kurihara, Noriyoshi

    Published in Journal of cellular biochemistry (01-04-2021)
    “…Paget's disease (PD) is characterized by increased numbers of abnormal osteoclasts (OCLs) that drive exuberant bone formation, but the mechanisms responsible…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels by Koyama, Hiroyuki, Yasuda, Satoshi, Kakoi, Shota, Ohata, Yasuhisa, Shimizu, Yuki, Hasegawa, Chie, Hayakawa, Akiko, Akiyama, Tomoyuki, Yagi, Takashi, Aotani, Daisuke, Imaeda, Kenro, Ozono, Keiichi, Kataoka, Hiromi, Tanaka, Tomohiro

    Published in Internal Medicine (15-03-2020)
    “…A 40-year-old Japanese woman presented to our hospital with general fatigue and muscle weakness. She had a history of premature loss of deciduous teeth at 4…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A family with brachydactyly mental retardation syndrome with a missense variant in HDAC4 by Takeyari, Shinji, Yamamoto, Kenichi, Fujiwara, Makoto, Ohata, Yasuhisa, Kitaoka, Taichi, Kubota, Takuo, Nagata, Miho, Ishihara, Yasuki, Miyashita, Yohei, Asano, Yoshihiro, Ozono, Keiichi

    Published in Clinical Pediatric Endocrinology (2023)
    “…Brachydactyly mental retardation syndrome (BDMR) or chromosome 2q37 deletion syndrome is a genetic disorder caused by 2q37 deletion or haploinsufficiency of…”
    Get full text
    Journal Article
  18. 18

    Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice by Miyagawa, Kazuaki, Yamazaki, Miwa, Kawai, Masanobu, Nishino, Jin, Koshimizu, Takao, Ohata, Yasuhisa, Tachikawa, Kanako, Mikuni-Takagaki, Yuko, Kogo, Mikihiko, Ozono, Keiichi, Michigami, Toshimi

    Published in PloS one (01-04-2014)
    “…Osteocytes express multiple genes involved in mineral metabolism including PHEX, FGF23, DMP1 and FAM20C. In Hyp mice, a murine model for X-linked…”
    Get full text
    Journal Article
  19. 19

    Current concepts in perinatal mineral metabolism by Ohata, Yasuhisa, Ozono, Keiichi, Michigami, Toshimi

    Published in Clinical Pediatric Endocrinology (01-01-2016)
    “…The serum levels of calcium (Ca) and phosphate are maintained higher in the fetus than in the pregnant mother, especially in late gestation, to meet the…”
    Get full text
    Journal Article
  20. 20

    Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells by Yamazaki, Miwa, Ozono, Keiichi, Okada, Tomoko, Tachikawa, Kanako, Kondou, Hiroki, Ohata, Yasuhisa, Michigami, Toshimi

    Published in Journal of cellular biochemistry (01-12-2010)
    “…Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced by bone and exerts its function in the target organs by binding the FGF receptor (FGFR)…”
    Get full text
    Journal Article